REPORT ID 3767

EMEA (Europe, Middle East and Africa) Cancer Diagnostics Market Report 2019

Publish Date
2019
Pages
106
Format
Electronic (PDF)

In this report, the EMEA Cancer Diagnostics market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Cancer Diagnostics for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Cancer Diagnostics market competition by top manufacturers/players, with Cancer Diagnostics sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    C.R. Bard, Inc.
    GE Healthcare
    Becton, Dickinson and Company
    Abbott
    Roche
    Thermo Fisher Scientific
    Agilent Technologies
    Siemens Healthcare
    Illumina

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Diagnostic Reagent
    Diagnostic Instrument

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Breast Cancer
    Lung Cancer
    Colorectal Cancer
    Melanoma
    Other Cancers

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Cancer Diagnostics Market  Report 2019
1 Cancer Diagnostics Overview
    1.1 Product Overview and Scope of Cancer Diagnostics
    1.2 Classification of Cancer Diagnostics
        1.2.1 EMEA Cancer Diagnostics Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Cancer Diagnostics Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Diagnostic Reagent
        1.2.4 Diagnostic Instrument
    1.3 EMEA Cancer Diagnostics Market by Application/End Users
        1.3.1 EMEA Cancer Diagnostics Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 Breast Cancer
        1.3.3 Lung Cancer
        1.3.4 Colorectal Cancer
        1.3.5 Melanoma
        1.3.6 Other Cancers
    1.4 EMEA Cancer Diagnostics Market by Region
        1.4.1 EMEA Cancer Diagnostics Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Cancer Diagnostics ( 2014-2024)
        1.5.1 EMEA Cancer Diagnostics Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Cancer Diagnostics Revenue and Growth Rate ( 2014-2024)

2 EMEA Cancer Diagnostics Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Cancer Diagnostics Market Competition by Players/Manufacturers
        2.1.1 EMEA Cancer Diagnostics Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Cancer Diagnostics Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Cancer Diagnostics Sale Price by Players ( 2014-2019)
    2.2 EMEA Cancer Diagnostics (Volume and Value) by Type/Product Category
        2.2.1 EMEA Cancer Diagnostics Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Cancer Diagnostics Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Cancer Diagnostics Sale Price by Type ( 2014-2019)
    2.3 EMEA Cancer Diagnostics (Volume) by Application
    2.4 EMEA Cancer Diagnostics (Volume and Value) by Region
        2.4.1 EMEA Cancer Diagnostics Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Cancer Diagnostics Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Cancer Diagnostics Sales Price by Region ( 2014-2019)

3 Europe Cancer Diagnostics (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Cancer Diagnostics Sales and Value ( 2014-2019)
        3.1.1 Europe Cancer Diagnostics Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Cancer Diagnostics Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Cancer Diagnostics Sales and Market Share by Type
    3.3 Europe Cancer Diagnostics Sales and Market Share by Application
    3.4 Europe Cancer Diagnostics Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Cancer Diagnostics Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Cancer Diagnostics Revenue by Countries ( 2014-2019)
        3.4.3 Germany Cancer Diagnostics Sales and Growth Rate ( 2014-2019)
        3.4.4 France Cancer Diagnostics Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Cancer Diagnostics Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Cancer Diagnostics Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Cancer Diagnostics Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Cancer Diagnostics Sales and Growth Rate ( 2014-2019)

4 Middle East Cancer Diagnostics (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Cancer Diagnostics Sales and Value ( 2014-2019)
        4.1.1 Middle East Cancer Diagnostics Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Cancer Diagnostics Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Cancer Diagnostics Sales and Market Share by Type
    4.3 Middle East Cancer Diagnostics Sales and Market Share by Application
    4.4 Middle East Cancer Diagnostics Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Cancer Diagnostics Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Cancer Diagnostics Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Cancer Diagnostics Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Cancer Diagnostics Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Cancer Diagnostics Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Cancer Diagnostics Sales and Growth Rate ( 2014-2019)

5 Africa Cancer Diagnostics (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Cancer Diagnostics Sales and Value ( 2014-2019)
        5.1.1 Africa Cancer Diagnostics Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Cancer Diagnostics Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Cancer Diagnostics Sales and Market Share by Type
    5.3 Africa Cancer Diagnostics Sales and Market Share by Application
    5.4 Africa Cancer Diagnostics Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Cancer Diagnostics Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Cancer Diagnostics Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Cancer Diagnostics Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Cancer Diagnostics Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Cancer Diagnostics Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Cancer Diagnostics Sales and Growth Rate ( 2014-2019)

6 EMEA Cancer Diagnostics Manufacturers/Players Profiles and Sales Data
    6.1 C.R. Bard, Inc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Cancer Diagnostics Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 C.R. Bard, Inc. Cancer Diagnostics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 GE Healthcare
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Cancer Diagnostics Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 GE Healthcare Cancer Diagnostics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Becton, Dickinson and Company
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Cancer Diagnostics Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Becton, Dickinson and Company Cancer Diagnostics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Abbott
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Cancer Diagnostics Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Abbott Cancer Diagnostics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Roche
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Cancer Diagnostics Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Roche Cancer Diagnostics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Thermo Fisher Scientific
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Cancer Diagnostics Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Thermo Fisher Scientific Cancer Diagnostics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Agilent Technologies
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Cancer Diagnostics Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Agilent Technologies Cancer Diagnostics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 Siemens Healthcare
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Cancer Diagnostics Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Siemens Healthcare Cancer Diagnostics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 Illumina
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Cancer Diagnostics Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Illumina Cancer Diagnostics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview

7 Cancer Diagnostics Manufacturing Cost Analysis
    7.1 Cancer Diagnostics Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Cancer Diagnostics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Cancer Diagnostics Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Cancer Diagnostics Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Cancer Diagnostics Market Forecast ( 2019-2025)
    11.1 EMEA Cancer Diagnostics Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Cancer Diagnostics Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Cancer Diagnostics Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Cancer Diagnostics Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Cancer Diagnostics Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Cancer Diagnostics Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Cancer Diagnostics Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Cancer Diagnostics Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Cancer Diagnostics Sales Forecast by Type ( 2019-2025)
    11.7 EMEA Cancer Diagnostics Sales Forecast by Application ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer